Hyperspectral multi-sensor aircraft developed

Share this on social media:

The first commercially available hyperspectral multi-sensor aircraft has been developed through a partnership between hyperspectral imaging company Specim, Diamond Aircraft Industries and Exogenesis. A full spectrum imager from Specim was successfully integrated onto one of Diamond Aircraft’s special mission airplanes, adding hyperspectral detection capabilities to assist in intelligence, surveillance and reconnaissance (ISR), mineralogy and environmental applications.

Diamond Aircraft Industries carried out test flights where the company is based in Wiener Neustadt, Austria, to demonstrate the hyperspectral capability. The Specim AisaFenix sensor was capable of finding all of the intended targets with zero false positives, as well as identifying potential unexploded weapons and revealing an area of forest that had strong soil-pollution.

Spatial, spectral and radiometric resolution of the sensor resulted in the ability to detect sub-pixel targets that were less than 3-9 per cent of the size of a single pixel. For example, a standard sized beverage can was detected from within an image pixel of 65cm GSD, based on its spectral signature.

Test-flights also made use of gyro-stabilised mounting from German company Somag for the sensor and IGI navigation and geo-referencing systems.

Recent News

12 February 2021

Video recorded at 2,800 frames per second has been used to test high-speed trains travelling through the newly opened Ceneri Base Tunnel in Switzerland

29 July 2020

The Perseverance rover contains 19 cameras, including seven scientific instruments. It will analyse the climate and geology of Mars, looking for signs of past life, as well as monitoring the Martian atmosphere

02 July 2020

Norwegian seafood firm, Lerøy, has installed hyperspectral cameras on processing lines to sort fish. The system is able to measure the amount of blood in white fish, which gives a grade of quality

09 June 2020

Hyperspectral imaging is being used in a research programme at hospitals in Maryland and New York to investigate the prognostic value of skin findings associated with Covid-19 infection